Quality by Design Assisted Development of Luliconazole Transethosomes in Gel for the Management of Candida albicans Infection

被引:0
|
作者
Singh, Gurmeet [1 ,2 ]
Narang, Raj Kumar [1 ,2 ]
机构
[1] IK Gujral Punjab Tech Univ, Dept Pharmaceut Sci, Kapurthala, Punjab, India
[2] ISF Coll Pharm, Dept Pharmaceut, GT Rd, Moga 142001, Punjab, India
关键词
luliconazole; transethosomes; Candida albicans; topical drug delivery; quality by design; Box-Behnken design; DELIVERY;
D O I
10.1089/adt.2023.059
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The objective of this study was to develop and evaluate a novel vesicular formulation of luliconazole (LUL) for the management of Candida albicans infection through a topical route. LUL-loaded transethosomes (LUL-TE) were prepared by the film hydration method and various independent and dependent variables were optimized using the Box-Behnken design. Selected critical material attributes were the content of phospholipids (X1), concentration of ethanol (X2), and amount of sodium cholate (X3). Formulated LUL-TE were characterized for percent entrapment efficiency, percent drug loading, vesicle size, and polydispersity index (PDI) and were incorporated into the carbomer gel base and further evaluated for gel characterizations. The prepared transethosomal gel (LUL-TE-CHG) was evaluated for pH, spreadability, viscosity, antifungal activity, and in vitro study. From the observed results, it was evident that the prepared LUL-TE-CHG was in the desired pH (6.2 +/- 0.45), spreadability [8.3 +/- 0.42 g/(cm<middle dot>s)], viscosity (236.1-19.2.26 mPa<middle dot>s), nanovesicle size (252 +/- 9.82), entrapment efficiency (85% +/- 5.24%), zeta potential (-34.05 +/- 3.52 mV), and PDI (0.233 +/- 0.002). The zone of inhibition results suggested that the LUL-TE-CHG formulation has the highest antifungal activity, that is, 5.83 +/- 0.15 mm(3). The in vitro results showed that drug release within 2 h was 18.1% +/- 2.0% and after that sustained release action, 83.2% +/- 1.7% within 8 h. Finally, to confirm the therapeutic efficacy of the developed formulation, fungal infection was induced by using C. albicans in Wistar rats. In vivo, skin irritation study and histopathology studies were performed in the disease-induced model. Animal experiments revealed that LUL-TE-CHG has significantly improved the diseased condition in Wistar rats. The results observed from the skin permeation and skin deposition profile ensure that the prepared novel LUL-loaded TE system had a higher permeation rate and increased retention time compared with LUL-CHG. The hydrogel incorporated with LUL could be a novel approach with safe and effective fungal treatment.
引用
收藏
页码:1 / 17
页数:17
相关论文
共 39 条
  • [1] RETRACTED: Development and Optimization of Luliconazole Spanlastics to Augment the Antifungal Activity against Candida albicans (Retracted Article)
    Alhakamy, Nabil A.
    Al-Rabia, Mohammed W.
    Md, Shadab
    Sirwi, Alaa
    Khayat, Selwan Saud
    AlOtaibi, Sahar Saad
    Hakami, Raghad Abkar
    Al Sadoun, Hadeel
    Eldakhakhny, Basmah Medhat
    Abdulaal, Wesam H.
    Aldawsari, Hibah M.
    Badr-Eldin, Shaimaa M.
    Elfaky, Mahmoud A.
    PHARMACEUTICS, 2021, 13 (07)
  • [2] Strategies for the management of Candida albicans infection
    Vaishali
    Khan, Johra
    Azmi, Wamik
    ANNALS OF PHYTOMEDICINE-AN INTERNATIONAL JOURNAL, 2021, 10 (02): : 145 - 156
  • [3] Oral Cavity and Candida albicans: Colonisation to the Development of Infection
    Patel, Mrudula
    PATHOGENS, 2022, 11 (03):
  • [4] Candida albicans skin infection in diabetic patients: An updated review of pathogenesis and management
    Shahabudin, Sakina
    Azmi, Nina Suhaity
    Lani, Mohd Nizam
    Mukhtar, Muhammad
    Hossain, Md. Sanower
    MYCOSES, 2024, 67 (06)
  • [5] Development and Optimization of Luliconazole Nanostructured Lipid Carriers Based Gel by Quality by Design its Skin Distribution Studies, Dermatokinetic Modeling & In-Vitro and Ex-Vivo correlation
    Bhargav, Eranti
    Reddy, Yiragamreddy Padmanabha
    Kunnatur, Koteshwara B.
    CURRENT DRUG DELIVERY, 2021, 18 (07) : 1029 - 1041
  • [6] Development of Gum-Acacia-Stabilized Silver Nanoparticles Gel of Rutin against Candida albicans
    Alqarni, Mohammed H.
    Foudah, Ahmed, I
    Alam, Aftab
    Salkini, Mohammad A.
    Muharram, Magdy M.
    Labrou, Nikolaos E.
    Kumar, Piyush
    GELS, 2022, 8 (08)
  • [7] A New Antifungal-Loaded Sol-Gel Can Prevent Candida albicans Prosthetic Joint Infection
    Garlito-Diaz, Hugo
    Esteban, Jaime
    Mediero, Aranzazu
    Alfredo Carias-Calix, Rafael
    Toirac, Beatriz
    Mulero, Francisca
    Faus-Rodrigo, Victor
    Jimenez-Morales, Antonia
    Calvo, Emilio
    Jairo Aguilera-Correa, John
    ANTIBIOTICS-BASEL, 2021, 10 (06):
  • [8] QbD-Driven Development and Characterization of Solid Lipid Nanoparticles (SLNs)-Based Nanogel of Luliconazole for the Effective Management of Dermal Fungal Infection
    Khurana, Gaurav
    Sharma, Vir Vikram
    Arora, Daisy
    JOURNAL OF PHARMACEUTICAL INNOVATION, 2023, 18 (04) : 2249 - 2264
  • [9] Design and Characterization of Citronella Oil-Loaded Micro-Emulgel for the Treatment of Candida Albicans Infection
    Singh, Shambhvi
    Chauhan, Shikha Baghel
    Gupta, Charu
    Singh, Indu
    Gupta, Annie
    Sharma, Shwetakshi
    Kawish, S. M.
    Rahman, Shakilur
    Iqbal, Muzaffar
    GELS, 2023, 9 (10)
  • [10] Design of a Simple Model of Candida albicans Biofilms Formed under Conditions of Flow: Development, Architecture, and Drug Resistance
    Uppuluri, Priya
    Chaturvedi, Ashok K.
    Lopez-Ribot, Jose L.
    MYCOPATHOLOGIA, 2009, 168 (03) : 101 - 109